China Meheco Group CoSHSE:600056 +1.11%65 Days Payable is 130.85 as of Mar. 2026, which is 52% above its 10-year median of 86.34. GuruFocus rates SHSE:600056 with a GF Score™ of 65/100 and a GF Value™ of ¥10.48 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, China Meheco Group Co ranks better than 74.78% on this metric.
The historical rank and industry rank for China Meheco Group Co's Days Payable or its related term are showing as below:
SHSE:600056'
s Days Payable Range Over the Past 10 Years
Min: 78.17 Med: 86.34 Max: 114.27
Current: 114.27
During the past 13 years, China Meheco Group Co's highest Days Payable was 114.27. The lowest was 78.17. And the median was 86.34.
SHSE:600056's Days Payable is ranked better than 74.78% of 115
companies
in the Medical Distribution industry
Industry Median: 79.81
vs SHSE:600056: 114.27
China Meheco Group Co Days Payable Historical Data
* Premium members only.
The historical data trend for China Meheco Group Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600056 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, China Meheco Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Meheco Group Co Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where China Meheco Group Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
China Meheco Group Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Meheco Group Co (SHSE:600056) has a Days Payable of 130.85 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Meheco Group Co and its competitors. This is 52% above median its historical median of 86.34. Over the past decade, China Meheco Group Co's Days Payable has ranged from 78.17 to 114.27. According to the industry distribution chart, China Meheco Group Co ranks #29 out of 115 companies in the Medical Distribution industry, placing it in the top 25.2%.
Is China Meheco Group Co's Days Payable too high?
China Meheco Group Co's current Days Payable of 130.85 is 52% above median its 10-year median of 86.34. Over the past 10 years, this metric has ranged from a low of 78.17 to a high of 114.27. The Medical Distribution industry median Days Payable is 79.81. China Meheco Group Co's value of 130.85 is 64% above this industry median. Based on the distribution chart, China Meheco Group Co ranks #29 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China Meheco Group Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China Meheco Group Co ranks #29 out of 115 companies for Days Payable. This puts China Meheco Group Co in the upper half of its industry. The industry median Days Payable is 79.81. China Meheco Group Co's value of 130.85 is 64% above this benchmark. Historically, China Meheco Group Co's own Days Payable has ranged from 78.17 to 114.27 over the past decade. While the company's 10-year median is 86.34 vs. the industry median of 79.81, China Meheco Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.81, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Meheco Group Co's current Days Payable of 130.85 is 64% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Meheco Group Co and its competitors. For the Medical Distribution industry, the median Days Payable is 79.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current Days Payable is 130.85, which is 52% above median its own 10-year median of 86.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.48, compared to a current price of ¥9.12 — trading 13% below its estimated fair value. The current Days Payable is 130.85, which is 52% above median its 10-year median of 86.34 and 64% above the Medical Distribution industry median of 79.81. China Meheco Group Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current Days Payable is 130.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?
Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued.
The current stock price of ¥9.12 is trading 13% below its estimated GF Value™ of ¥10.48.
GuruFocus considers China Meheco Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:600056:
Days Payable: 130.85 (52% above median its 10-year median of 86.34)
GF Value™: ¥10.48 vs. price of ¥9.12 (13% below fair value)
Industry Position: 64% above the Medical Distribution median (#29 of 115)
No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
65GF Score
Get the complete analysis for SHSE:600056
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600056 has been successfully added to your 
